Literature DB >> 8435994

Sharing the care of diabetic patients between hospital and general practitioners: does it work?

P L Hoskins1, P M Fowler, M Constantino, J Forrest, D K Yue, J R Turtle.   

Abstract

A randomized controlled trial was conducted to compare three forms of diabetes follow-up: (1) general practitioner care, (2) a system of care shared between the general practitioner (GP) and clinic and (3) conventional clinic care. Two hundred and six diabetic patients without significant diabetes-related or other medical complications were randomized to one of these follow-up systems. Metabolic control and blood pressure improved significantly and equally in all three groups (p < 0.05). The shared care group performed as well as or better than either of the other two groups in all other outcome measures. In particular, final attendance rates were 72% for shared care compared with only 35% for GP care and 53% for clinic care. Data collection rates for shared care were comparable with the clinic group for random blood glucose (88.9% vs 95.1%), weight (93.5% vs 98.3%), and blood pressure (94.8% vs 92.7%). Only in the case of glycosylated haemoglobin did shared care have poorer data collection (66.0% vs 98.4%). In all these parameters, except blood pressure, shared care out-performed the GP group. We conclude that with adequate support from and communication with hospital-based diabetes services, GPs are capable of providing care appropriate to the needs of uncomplicated diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435994     DOI: 10.1111/j.1464-5491.1993.tb02001.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  12 in total

1.  Shared care: a qualitative study of GPs' and hospital doctors' views on prescribing specialist medicines.

Authors:  R Horne; E Mailey; S Frost; R Lea
Journal:  Br J Gen Pract       Date:  2001-03       Impact factor: 5.386

Review 2.  Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings.

Authors:  C M Renders; G D Valk; S Griffin; E H Wagner; J T Eijk; W J Assendelft
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 3.  The economics of shared care packages.

Authors:  S M McGhee; A J Hedley
Journal:  Pharmacoeconomics       Date:  1996-09       Impact factor: 4.981

4.  Rationale and implementation of the SLICK project: Screening for Limb, I-Eye, Cardiovascular and Kidney (SLICK) complications in individuals with type 2 diabetes in Alberta's First Nations communities.

Authors:  Shainoor Virani; David Strong; Matthew Tennant; Mark Greve; Heather Young; Sandra Shade; Mebs Kanji; Ellen Toth
Journal:  Can J Public Health       Date:  2006 May-Jun

5.  Use of chronic care model elements is associated with higher-quality care for diabetes.

Authors:  Paul A Nutting; W Perry Dickinson; L Miriam Dickinson; Candace C Nelson; Diane K King; Benjamin F Crabtree; Russell E Glasgow
Journal:  Ann Fam Med       Date:  2007 Jan-Feb       Impact factor: 5.166

6.  Integrated care for diabetes: clinical, psychosocial, and economic evaluation. Diabetes Integrated Care Evaluation Team.

Authors: 
Journal:  BMJ       Date:  1994-05-07

7.  Diabetes care in general practice: meta-analysis of randomised control trials.

Authors:  S Griffin
Journal:  BMJ       Date:  1998-08-08

Review 8.  Shared care across the interface between primary and specialty care in management of long term conditions.

Authors:  Susan M Smith; Gráinne Cousins; Barbara Clyne; Shane Allwright; Tom O'Dowd
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

9.  Community diabetes: an East London perspective.

Authors:  Susan V Gelding; Shanti Vijayaraghavan; Clare Davison; Tahseen A Chowdhury
Journal:  J R Soc Med       Date:  2005-03       Impact factor: 18.000

10.  Shared care management of patients with type 2 diabetes across the primary and secondary healthcare sectors: study protocol for a randomised controlled trial.

Authors:  Lene Munch; Birgitte Bennich; Anne B Arreskov; Dorthe Overgaard; Hanne Konradsen; Filip K Knop; Tina Vilsbøll; Michael E Røder
Journal:  Trials       Date:  2016-06-04       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.